NEWYou can now listen to Fox News articles!
Missouri Attorney General Catherine Hanaway announced Thursday she is expanding the state’s fight against mail-order abortion pills, targeting a recently approved generic version of mifepristone that she argues sends women to hospitals with “life-threatening complications” and is being pushed into the marketplace without “basic medical safeguards.”
The filing challenges the Food and Drug Administration’s (FDA) Sept. 30 approval of a generic mifepristone produced by Evita Solutions, arguing that the drug’s risks are “well-documented and worsening with further study.”
The lawsuit alleges manufacturers have relied on “weakened safety standards” that were “originally designed to catch dangerous conditions such as ectopic pregnancies,” which can only be identified through an in-person medical exam.
“Mifepristone is sending women to the hospital with life-threatening complications, and yet drug companies continue pushing new versions of it into the market without basic medical safeguards,” Hanaway said. “Mail-order abortion drugs are dangerous when taken without in-person care, and Missouri will not stand by while manufacturers gamble with women’s lives.”
HAWLEY BLASTS FDA APPROVAL OF NEW ABORTION DRUG, CITES SAFETY AND TRUST CONCERNS
Catherine Hanaway speaks to reporters after Missouri Gov. Mike Kehoe announced her appointment as the state’s next attorney general, Aug. 19, in Jefferson City, Mo. (AP Photo/David A. Lieb)
The case builds on Missouri’s multi-state challenge to what officials allege is the FDA’s “dismantling of critical safety protections” surrounding mifepristone.
Federal law has long banned the mailing of abortion drugs, yet distributors and telehealth networks have built a nationwide system that delivers the pills to women in every state, often without in-person medical screenings or follow-up care.
Missouri, joined by Kansas and Idaho, is asking the court to block the new approval, restore…
